MedPath
TGA Approval

Hospira Deferoxamine Mesylate 500 mg Powder for Injection Vial (378150)

378150

Hospira Deferoxamine Mesylate 500 mg Powder for Injection Vial

Hospira Australia Pty Ltd

November 17, 2021

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

desferrioxamine mesilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.